Picture of SCHOTT Pharma AG & Co KgaA logo

1SXP SCHOTT Pharma AG & Co KgaA Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Momentum

Relative Strength (%)
1m-12.01%
3m-33.22%
6m-22.33%
1yrn/a
Volume Change (%)
10d/3m-50.45%
Price vs... (%)
52w High-36.87%
50d MA-20.07%
200d MA-18.79%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)25.75
PEG Ratio (f)2.95
EPS Growth (f)9.56%
Dividend Yield (f)0.63%
Valuation (ttm)IndustryMarket
Price to Book Value5.74
Price to Tang. Book5.99
Price to Free Cashflow114.03
Price to Sales4.56
EV to EBITDA17.59

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital21.18%
Return on Equity43.96%
Operating Margin22.05%

Financial Summary

Year End 30th SepUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€mn/a584.23648.67821.14898.6974.941,106.9115.43%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a+30.71+32.7+9.7-0.05+13.49n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202430th Sep 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of SCHOTT Pharma AG & Co KgaA EPS forecast chart

Profile Summary

SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

Directors

    Last Annual
    September 30th, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    May 10th, 2022
    Public Since
    September 28th, 2023
    No. of Employees
    4,646
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    de flag iconXETRA
    Shares in Issue
    150,614,616

    1SXP Share Price Performance

    FAQ